Westfield Capital Management Company »

Neurocrine Biosciences shares owned by Westfield Capital Management Company

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Westfield Capital Management Company from 13F filings

Historical chart of Westfield Capital Management Company investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Westfield Capital Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Westfield Capital Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $78M 594k 131.76
2023-09-30 $73M 649k 112.50
2023-06-30 $35M 375k 94.30
2023-03-31 $26M 255k 101.22
2022-12-31 $33M 273k 119.44
2022-09-30 $49M 460k 106.21
2022-06-30 $52M 529k 97.48
2022-03-31 $52M 555k 93.75
2021-12-31 $60M 706k 85.17
2021-09-30 $69M 723k 95.91
2021-06-30 $60M 615k 97.32
2021-03-31 $52M 536k 97.25
2020-12-31 $45M 464k 95.85
2020-09-30 $39M 404k 96.16
2020-06-30 $49M 400k 122.00
2020-03-31 $56M 648k 86.55
2019-03-31 $28M 317k 88.10
2018-12-31 $10M 144k 71.41
2018-06-30 $18M 185k 98.24
2017-09-30 $24M 383k 61.28
2017-06-30 $64M 1.4M 46.00
2017-03-31 $51M 1.2M 43.30
2016-12-31 $54M 1.4M 38.70
2016-09-30 $64M 1.3M 50.64
2016-06-30 $58M 1.3M 45.45
2016-03-31 $52M 1.3M 39.55
2015-12-31 $69M 1.2M 56.57
2015-09-30 $46M 1.1M 39.79
2015-06-30 $56M 1.2M 47.76
2015-03-31 $91M 2.3M 39.71